If passed, this bill would require health benefit plans to provide coverage for prescribed, orally administered anticancer drugs. The bill states coverage for orally administered anticancer drugs would not be subject to prior authorization dollar limits, co-payments, coinsurance or deductible provisions or out of pocket costs. The bill also states insurers cannot reclassify anticancer drugs in order to comply with this bill.
Coverage for Oral Anti-Cancer Drugs
More Posts in 2017 Legislative Session
Share this Post